Vanguard Group’s MiNK Therapeutics INKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $178K | Hold |
23,744
| – | – | ﹤0.01% | 4099 |
|
|
2025
Q1 | $205K | Sell |
23,744
-210,438
| -90% | -$1.82M | ﹤0.01% | 4072 |
|
|
2024
Q4 | $163K | Hold |
234,182
| – | – | ﹤0.01% | 4125 |
|
|
2024
Q3 | $176K | Hold |
234,182
| – | – | ﹤0.01% | 4153 |
|
|
2024
Q2 | $222K | Hold |
234,182
| – | – | ﹤0.01% | 4150 |
|
|
2024
Q1 | $213K | Hold |
234,182
| – | – | ﹤0.01% | 4170 |
|
|
2023
Q4 | $251K | Hold |
234,182
| – | – | ﹤0.01% | 4186 |
|
|
2023
Q3 | $258K | Sell |
234,182
-7,001
| -3% | -$7.7K | ﹤0.01% | 4204 |
|
|
2023
Q2 | $506K | Buy |
241,183
+192,076
| +391% | +$403K | ﹤0.01% | 4119 |
|
|
2023
Q1 | $93.1K | Hold |
49,107
| – | – | ﹤0.01% | 4415 |
|
|
2022
Q4 | $128K | Hold |
49,107
| – | – | ﹤0.01% | 4365 |
|
|
2022
Q3 | $104K | Buy |
+49,107
| New | +$104K | ﹤0.01% | 4489 |
|
|
2022
Q2 | – | Sell |
-10,348
| Closed | -$23K | – | 4629 |
|
|
2022
Q1 | $23K | Sell |
10,348
-423
| -4% | -$940 | ﹤0.01% | 4624 |
|
|
2021
Q4 | $48K | Buy |
+10,771
| New | +$48K | ﹤0.01% | 4626 |
|